XML 28 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
January 2024 [Member]
August 2024 [Member]
December 2025 [Member]
June 2025 [Member]
Common Stock
Common Stock
January 2024 [Member]
Common Stock
August 2024 [Member]
Common Stock
December 2025 [Member]
Common Stock
June 2025 [Member]
Additional Paid In Capital
Additional Paid In Capital
January 2024 [Member]
Additional Paid In Capital
August 2024 [Member]
Additional Paid In Capital
December 2025 [Member]
Additional Paid In Capital
June 2025 [Member]
Accumulated Deficit
Accumulated Other Comprehensive Gain/(Loss)
Beginning Balance at Dec. 31, 2022 $ 490,151         $ 6         $ 878,884         $ (383,790) $ (4,949)
Beginning Balance at Dec. 31, 2022           55,039,380                      
Exercise of Stock Options 2,860                   2,860            
Exercise of Stock Options, Shares           441,759                      
Vesting Restricted Stock, Shares           39,511                      
Stock-based compensation expense 43,118                   43,118            
Unrealized gain/Loss on marketable securities 4,397                               4,397
Net Income (Loss) (146,962)                             (146,962)  
Issuance of shares under ESPP 1,407                   1,407            
Issuance of shares under ESPP, Share           64,655                      
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance 0                                
Ending Balance at Dec. 31, 2023 394,971         $ 6         926,269         (530,752) (552)
Ending Balance, Shares at Dec. 31, 2023           55,585,305                      
Exercise of Stock Options 11,790                   11,790            
Exercise of Stock Options, Shares           799,117                      
Vesting Restricted Stock, Shares           174,463                      
Stock-based compensation expense 55,012                   55,012            
Unrealized gain/Loss on marketable securities (933)                               (933)
Net Income (Loss) (223,858)                             (223,858)  
Issuance of shares under ESPP 2,018                   2,018            
Issuance of shares under ESPP, Share           97,164                      
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance (301,373) $ 301,373 $ 246,506         $ 1       $ 301,373 $ 246,505        
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares             3,884,158 2,830,533                  
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs 48,740                   48,740            
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs, Shares           1,519,453                      
Ending Balance at Dec. 31, 2024 835,619         $ 7         1,591,707         (754,610) (1,485)
Ending Balance, Shares at Dec. 31, 2024           64,890,193                      
Exercise of Stock Options 61,621                   61,621            
Exercise of Stock Options, Shares           2,140,098                      
Vesting Restricted Stock, Shares           284,026                      
Stock-based compensation expense 59,904                   59,904            
Unrealized gain/Loss on marketable securities 3,285                               3,285
Net Income (Loss) (311,351)                             (311,351)  
Issuance of shares under ESPP 1,685                   1,685            
Issuance of shares under ESPP, Share           59,715                      
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance 0       $ 272,671                   $ 272,671    
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares                   5,899,500              
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs       $ 656,230         $ 1         $ 656,229      
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs, Shares                 8,050,000                
Ending Balance at Dec. 31, 2025 $ 1,579,664         $ 8         $ 2,643,817         $ (1,065,961) $ 1,800
Ending Balance, Shares at Dec. 31, 2025           81,323,532